Discontinuation report TEVA-PREGABALIN
Report ID | 120033 |
Drug Identification Number | 02361183 |
Brand name | TEVA-PREGABALIN |
Common or Proper name | PREGABALIN 75MG CAP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 75MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 60 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2020-03-25 |
Remaining supply date | 2020-03-25 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-07-10 | English | Compare |
v2 | 2020-07-10 | French | Compare |
Showing 1 to 2 of 2